# Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer

> **NCT03465982** · NA · RECRUITING · sponsor: **Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria** · enrollment: 340 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Surgery after 8 weeks from chemoradiation treatment
- **PROCEDURE:** Surgery after 12 weeks from chemoradiation treatment

## Key facts

- **NCT ID:** NCT03465982
- **Lead sponsor:** Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-06-05
- **Primary completion:** 2025-06-05
- **Final completion:** 2029-06-05
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465982, "Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03465982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*